AzTrials
AzTrials

Impacted Mandibular Third MolarNCT07012564

Does Vitamin C Improve Postoperative Healing

A study testing Vitamin C in people with Impacted Mandibular Third Molar, run by Hacettepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized, split-mouth clinical trial investigates the effect of oral vitamin C supplementation on postoperative recovery following the surgical extraction of impacted mandibular third molars. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Impacted Mandibular Third Molar
What is being tested?
Vitamin C
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
56 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2024to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-35 years
  • Systemically healthy
  • Non-smoker
  • No alcohol or substance abuse
  • Bilateral impacted mandibular third molars
  • Mesioangular impaction with a Pederson index of 5-6
  • Voluntary participation
  • Ability and willingness to attend follow-up visits

Who cannot join

  • Pregnancy or lactation
  • Presence of infection or pain related to third molars
  • Associated pathological conditions (e.g., cysts or tumors)
  • History of previous mandibular third molar extraction
  • Congenital absence of third molars
  • Known allergy to any drug or substance used in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Hacettepe University Faculty of Dentistry

    Ankara, 06100

Other trials in Turkey (Türkiye)

About this study

Official title: Does Vitamin C Improve Postoperative Healing: A Randomized Split-Mouth Clinical Trial After Impacted Mandibular Third Molar Surgery

This randomized, split-mouth clinical trial investigates the effect of oral vitamin C supplementation on postoperative recovery following the surgical extraction of impacted mandibular third molars. Fifty-six healthy patients underwent bilateral extractions, with each side randomly assigned to receive either 1000 mg of oral vitamin C or a placebo. The supplementation began one day before surgery and continued through postoperative day 7. The outcome measures included facial swelling assessed through linear measurements (tragus-pogonion, tragus-commissure labiorum, and lateral canthus of the eye-angulus mandible), pain using a visual analog scale (VAS), trismus based on maximum interincisal opening, and early wound healing assessed with the Landry healing index. Analgesic consumption was also recorded. Pain was evaluated using VAS on days 1, 2, and 7. Edema, trismus, and early wound healing were evaluated on postoperative days 2 and 7. The study aims to determine whether vitamin C reduces edema, pain, and trismus, and enhances early soft tissue healing compared to placebo.

Read the detailed description

This randomized, split-mouth clinical trial aimed to investigate the effect of oral vitamin C supplementation on postoperative recovery following the surgical extraction of impacted mandibular third molars. A total of 56 healthy patients requiring bilateral lower third molar extractions were included in the study. Each patient underwent two separate surgeries on both sides, with each side randomly assigned to receive either 1000 mg of oral vitamin C or a placebo.

Vitamin C supplementation started one day prior to surgery and continued for seven days postoperatively. The primary outcomes of the study were facial swelling, pain, trismus, and early soft tissue healing. Facial swelling was assessed using three linear measurements between specific anatomical landmarks: tragus-pogonion, tragus-labial commissure, and lateral canthus of the eye-angulus mandible. Trismus was measured based on maximum interincisal distance. Pain was evaluated using the visual analog scale (VAS) on postoperative days 1, 2, and 7. Edema, trismus, and early wound healing were assessed on postoperative days 2 and 7. Early wound healing was scored using the Landry healing index. Analgesic consumption was also recorded during the postoperative period.

This study was designed to evaluate whether vitamin C supplementation could reduce postoperative edema, pain, and trismus, and improve early soft tissue healing in comparison to placebo in the context of oral surgical procedures. The findings may provide evidence to support the use of vitamin C as an adjunctive therapy in oral surgery.

Being tested
Vitamin C, Placebo
Keywords
Vitamin C, Wound Healing, Third Molar Surgery, Oral Surgery, Postoperative Recovery, Trismus, Facial Swelling, Pain, Analgesic Use, Edema
Medical subject headings
Trismus, Pain, Edema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitamin CDietary supplement

    1000 mg oral vitamin C tablet taken daily from one day before surgery to postoperative day 7.

  • PlaceboOther

    Identical-appearing oral tablet taken on the same schedule as the vitamin C group.

Study groups in NCT07012564
Study groupRoleWhat they receive
Vitamin CExperimentalPatients received 1000 mg of oral vitamin C daily starting one day before surgery through postoperative day 7.
Receives: Dietary Supplement: Vitamin C
PlaceboPlacebo comparatorPatients received an identical-looking placebo tablet once daily for the same duration.
Receives: Other: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Facial Swelling

    Facial swelling was measured using three linear distances: tragus-pogonion, tragus-labial commissure, and lateral canthus-mandibular angle.

    Measured: Postoperative Day 2 and Day 7

  2. Postoperative Pain Score (VAS)

    Pain intensity was assessed using a 10-cm visual analog scale (VAS), with 0 = no pain and 10 = worst possible pain.

    Measured: Postoperative Days 1, 2, and 7

Secondary outcomes (3)
  1. Trismus (Maximum Interincisal Opening)

    Trismus was assessed by measuring the maximum interincisal distance in millimeters using a caliper.

    Measured: Postoperative Days 2 and 7

  2. Early Wound Healing (Landry Healing Index)

    Soft tissue healing was evaluated using the Landry healing index, which scores wound healing on a 5-point scale based on tissue color, bleeding, and granulation.

    Measured: Postoperative Days 2 and 7

  3. Analgesic Consumption

    : The number of analgesic tablets consumed was recorded for each participant.

    Measured: Postoperative Days 1,2 and 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2025
  2. Study start1 Jun 2024
  3. Primary completion15 Feb 2025
  4. Study completion1 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
This study employed a split-mouth crossover design, where each participant served as their own control. Bilateral surgical extractions of impacted mandibular third molars were performed in two separate sessions. The intervention (vitamin C) and the control (placebo) were randomly assigned to either the left or right surgical site, allowing intra-individual comparison of postoperative outcomes.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07012564
Sponsor's protocol ID
HU-ADÇC-AA-01
Status last verified
May 2025
First submitted
31 May 2025
Last updated
10 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Vitamin C in people with Impacted Mandibular Third Molar, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Facial Swelling (time frame: Postoperative Day 2 and Day 7). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in